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Abstract
Aims—Community outreach services play an important role in infectious disease prevention and 
engaging drug users not currently in treatment. However, fewer than half of US substance abuse 
treatment units provide these services and many have little financial incentive to do so. Unit 
directors generally have latitude about scope of services, including the level of outreach provided 
to the community. The current study examines how directors’ interactions with external 
stakeholders affect substance abuse treatment units’ provision of community outreach services.
Methods—Cross-sectional logistic and Poisson regression analyses were conducted on a national 
sample of US outpatient substance abuse treatment units (N = 547).
Results—Findings suggest that the amount of time directors spent with licensing and monitoring 
associations was associated with provision of a greater number of community outreach services, 
while time spent with professional and occupational associations was associated with provision of 
off-site human immunodeficiency virus and hepatitis C testing. Several other director attributes 
and organizational characteristics also emerged as significant.
Conclusions—External stakeholders with whom substance abuse treatment directors interact 
may influence community outreach through their effects on treatment directors’ strategic 
priorities. Implications for policy and prevention efforts are discussed.
BACKGROUND
Despite widespread efforts by federal agencies and activists to prevent the transmission of 
chronic blood-borne diseases, human immunodeficiency virus (HIV)/acquired 
Correspondence: Emmeline Chuang, Division of Health Management and Policy, Graduate School of Public Health, San Diego State 
University, San Diego, CA, USA. Tel: 1-619-594-6439. Fax: 1-619-594-6112. echuang@mail.sdsu.edu. 
Declaration of interest: The authors report no conflicts of interest.
HHS Public Access
Author manuscript
Drugs (Abingdon Engl). Author manuscript; available in PMC 2017 November 21.
Published in final edited form as:













immunodeficiency syndrome (AIDS) and hepatitis C (HCV) continue to pose significant 
threats to public health (Des Jarlais & Semaan, 2008). In the United States, more than 
18,000 people with AIDS die each year (CDC, 2011), and HCV is a major contributor to 
chronic liver disease, with annual associated health care costs of more than $600 million 
(Wong, McQuillan, McHutchison, & Poynard, 2000). Currently, over 1.1 million Americans 
live with HIV/AIDS (Campsmith, Rhodes, Hall, & Green, 2008) and an estimated 4 million 
have chronic HCV (Amon et al., 2008; Armstrong et al., 2006). While transmission rates for 
both diseases have stabilized since the mid-1990s (CDC, 2011), 40,000–56,000 individuals 
continue to be infected with HCV and HIV respectively, each year (Fenton & Valdiserri, 
2006; Williams, Bell, Kuhnert, & Alter, 2011).
The incidence of new infections is particularly high among men and women who use illicit 
drugs (Backmund, Reimer, Meyer, Gerlach, & Zachoval, 2005; Des Jarlais et al., 2007), 
especially injection drug users (IDUs). Elevated risk of infection among drug users has been 
attributed to both increased prevalence of HIV/AIDS and HCV as well as a greater 
propensity to engage in risky behaviours such as sharing drug equipment and having 
unprotected sex (Carey et al., 2009; Hagan et al., 2001). HIV and HCV prevention services 
such as rapid testing, behavioural interventions, and needle exchange programs can lower 
rates of drug equipment re-use and reduce sexual risk behaviors (Edlin, 2004; Holtzman et 
al., 2009; Semaan et al., 2002). Prevention efforts also play an important role in making 
infected individuals aware of their disease status and connecting them to appropriate 
treatment options.
Drug users tend to be medically underserved and difficult to reach in traditional health care 
settings (Chitwood, McBride, French, & Cornerford, 1999). Outpatient substance abuse 
treatment units (OSATs) serve the majority (62%) of individuals entering substance abuse 
treatment in the United States (Grella, Etheridge, Joshi, & Anglin, 2000) and are well-
positioned to educate drug users about infectious diseases (Hagan, Strauss, Astone, & Des 
Jarlais, 2005; Sorenson & Copeland, 2000). Governmental agencies such as the National 
Institutes of Health (NIH), the Centres for Disease Control and Prevention (CDC), and the 
Substance Abuse Mental Health Services Administration (SAMHSA) all acknowledge the 
important role that substance abuse treatment units play in infectious disease control, and 
actively promote the provision of both testing and community outreach services by OSATs 
and other treatment units as part of their ‘Seek, Test and Treat’ paradigm for addressing the 
HIV and HCV epidemics (Kerker & Dore, 2006; Kresina, Hoffman, Lubran, & Clark, 2007; 
SAMHSA, 2010).
However, despite federal interest in these activities, the provision of HIV and HCV 
prevention services by OSATs remains uneven (Grella et al., 2000). The majority of OSATs 
offer some form of HIV and/or HCV testing services on-site (Astone, Strauss, Vassilev, & 
Des Jarlais, 2003; Pollack & D’Aunno, 2010), but direct provision of off-site testing and 
other community outreach services is far less prevalent. In fact, research suggests that the 
breadth and intensity of community outreach services offered by OSATs, measured both by 
the number of units offering these services and by the number of services offered, has 
actually decreased over time (D’Aunno, 2006; Pollack, D’Aunno, & Lamar, 2006). Off-site 
testing and community outreach services play an important role in raising awareness of 
Chuang et al. Page 2













infectious disease among street drug users and individuals not currently in treatment 
(English & the LONGSCAN Investigators, 1997; Porter, Metzger, & Scotti, 2002), and can 
increase treatment utilization in high-risk populations (Barnett, Manly, & Cicchetti, 1993). 
However, incorporating such services can be challenging for agencies given limited 
resources (Bini et al., 2011; Haynes et al., 2011). For example, state health departments 
often require specific staff training for certification to conduct HIV or HCV testing and, 
despite their important contribution to the nation’s public health, HIV and HCV prevention 
activities are typically under-reimbursed if they are reimbursed at all (Dore, 1999; Weisz, 
Donenberg, Han, & Weiss, 1995). Consequently, commitment from unit leadership may be 
essential to units’ decisions to provide these services.
Previous research has identified a range of organizational factors that significantly influence 
OSAT provision of prevention and outreach services (e.g. per capita income, unit size, etc.) 
(Strauss, Falkin, Vassilev, Des Jarlais, & Astone, 2002; Wells, Lemak, & D’Aunno, 2006), 
but the role of organizational leadership is not commonly explored. This is surprising 
because substance abuse treatment directors, who are responsible for organizational strategy 
and performance, significantly influence programmatic decisions as well as unit survival 
(Proctor et al., 2007; Wells, Lemak, & D’Aunno, 2005).
The current study uses data from a national survey of US OSATs to examine how directors’ 
behaviours correlate with OSATs’ provision of community outreach services. Specific 
director behaviours hypothesized to impact service provision include the amount of time 
directors spend managing relations with external stakeholders such as monitoring or 
licensing organizations, professional or occupational organizations, other treatment 
providers, policymakers and members of the local community. Community outreach services 
previously found effective include offering HIV and HCV testing in high prevalence areas, 
as well as employing multiple strategies such as reaching out to members of high-risk 
individuals’ sexual and social networks for testing, counseling and care; and utilization of 
harm-reduction approaches such as needle exchange programs (Janssen et al., 2001; Marks, 
Crepaz, Senterfritt, & Janssen, 2005).
DIRECTORS’ INTERACTION WITH EXTERNAL STAKEHOLDERS
OSATs are typically small organizations that depend heavily on external stakeholders such 
as referral sources, licensing and accrediting entities, professional associations and 
legislators for their survival (Alexander, Wells, Jiang, & Pollack, 2008). Directors’ 
interactions with these stakeholders, also known as ‘boundary-spanning’, may affect the 
nature of discretionary and under-funded services such as prevention by shaping director 
priorities. For example, directors who interact with local stakeholders may be more aware of 
community prevention needs. Many federal agencies and accrediting bodies also emphasize 
the importance of HIV and HCV prevention (Kerker & Dore, 2006; Kresina et al., 2007; 
SAMHSA, 2010). Thus, directors’ boundary spanning activities are hypothesized to impact 
OSAT provision of HIV and HCV community outreach services both because they can 
shape directors’ beliefs about the need for HIV and HCV prevention and because they can 
serve as a way for units to convey their public health commitment to other agencies.
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Previous research suggests that directors do take cues about prevention services from their 
external environments. Data from the 1990 wave of the Drug Abuse Treatment System 
Survey (DATSS) revealed that directors’ participation in professional development activities 
to learn about trends in substance abuse affected whether units provided HIV/AIDS 
education (Clapp, 1998). Similarly, two studies utilizing 1988–1995 and 1988–2000 
National DATSS (NDATSS) data found that directors’ participation in professional 
development activities predicted treatment units’ provision of community outreach services 
(D’Aunno, Vaughn, & McElroy, 1999; Pollack et al., 2006). However, prior research has not 
examined how directors’ interactions with other stakeholders such as legislators, referral 
agencies and licensing or accrediting entities affect OSAT provision of prevention services.
The current study extends inquiry into OSAT prevention activities in several ways. First, this 
study examines how total director time spent with each type of stakeholder affects unit 
prevention activities. In increasingly resource-constrained environments, directors’ 
interactions with key sources of funding and client referrals may have a greater effect on 
programmatic priorities than professional development activities. Understanding which 
relationships are associated with OSAT community orientation can help policy-makers and 
activists identify ways to encourage prevention activities. Second, prior research has focused 
primarily on identifying factors affecting OSAT provision of on-site HIV testing and 
counselling to current clients (Pollack & D’Aunno, 2010; Pollack et al., 2006). Since the 
majority of people with substance-use disorders do not enter treatment (SAMHSA, 2008), 
the off-site testing and community outreach activities identified in this study represent an 
important opportunity for OSATs to engage with prospective clients as well as a potential 
public health leverage point for disease prevention. While prevention of communicable 
disease is often viewed as the responsibility of local public health departments, recent cuts 
have diminished these departments’ already scarce resources for providing such services 
(NACCHO, 2012). Substance abuse treatment providers are also uniquely positioned to 
work effectively with illicit drug users, a population in which the incidence of new infections 
remains high (Backmund et al., 2005; Des Jarlais et al., 2007). Given these conditions as 
well as a growing body of literature demonstrating that multi-modal community outreach 
activities are more effective than any single strategy (Crepaz et al., 2006; Lyles et al., 2007; 
Rotheram-Borus, Swendeman, & Chovnick, 2009; Semaan et al., 2002), the current study’s 
focus on a range of prevention activities represents an important next step on a topic last 
addressed in the mid-1990s (D’Aunno et al., 1999). Finally, to the best of our knowledge, 
this study is the first to examine factors affecting OSAT provision of HCV testing, a disease 
that is more prevalent than HIV but whose prevention has received less attention as a 
programmatic priority for US substance abuse treatment units (Armstrong et al., 2006).
METHODS
Data
The data used for this study were from a nationally representative sample of US OSATs 
surveyed in 2005 as part of the NDATSS. The NDATSS was a longitudinal study of OSATs 
conducted by the Institute for Social Research at the University of Michigan. In the 
NDATSS, an OSAT unit was defined as a physical facility in which the majority of resources 
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(>50%) were dedicated to treat individuals with substance abuse problems, including alcohol 
and other drugs, on an outpatient basis. Active duty military, Veteran’s Administration, and 
correctional facility programmes were excluded, as were units that treated only alcohol 
abuse.
The NDATSS used a stratified, proportional random sample drawn from the Institute of 
Social Research’s sampling frame of the nation’s OSAT units. The sample method and 
procedures of NDATSS have been described previously (Heeringa, 1996). Briefly, the 
NDATSS used a mixed-panel design, which combined elements from panel and cross-
sectional designs. Data were collected from the same national sample of OSAT units 
sampled and screened in prior waves of the study. These panel units were replenished in 
subsequent waves with new groups of OSAT units, randomly selected so that the full sample 
would be representative of the US outpatient treatment systems in a given year. The 2005 
sample, representing the sixth and final wave of the NDATSS data, included 566 units, 
reflecting an 88% response rate. Of these 566 units, interviews with directors were 
conducted for 547 units.
Several steps were taken to produce reliable and valid telephone survey data, including two 
pre-tests, substantial interviewer training, extensive checks for consistency within and 
between sections of the survey instrument, and when necessary, re-contacts with respondents 
(Groves, 1988). NDATSS data were collected through separate telephone surveys of the 
administrative director and clinical supervisor at each OSAT unit. Unit directors provided 
information concerning units’ sources of revenue, ownership and affiliation with other 
organizations. Clinical supervisors provided information about treatment practices and client 
characteristics. After the data were collected, extensive reliability checks were performed 
within each survey. Results were also compared between surveys to further confirm validity. 
These checks revealed very high levels of internal consistency within the NDATSS data.
Levels of item non-response were generally very low, and did not exceed 4% for any single 
item. Subsequent list-wise deletion reduced the final analytic sample to 489 units. 
Examination of missing data patterns as well as t-test comparisons of the means of all 
variables used in the analyses did not reveal any statistically significant differences due to 
item non-response (Lemak & Alexander, 2001). When data are missing at random, multiple 
imputation yields results that are less biased than complete case analysis (Jones, 2004). 
Therefore, we conducted multiple imputation using the multivariate normal imputation 
method within the Stata 11.0 MI module in order to maintain the full sample of 547 units 
(StataCorp, 2009). A total of 20 imputations were used in order to reduce sampling error 
(Choi & Ryan, 2006). Sensitivity analyses conducted using the method of multiple 
imputation by chained equations did not alter the pattern of results (Royston, 2005).
Measures
Provision of off-site testing and other community outreach activities was measured using 
three variables, two dichotomous and one count, that cumulatively represent a range of HIV 
and HCV prevention services offered by OSATs outside of their facilities: (1) off-site HIV 
testing, a dichotomous variable set = 1 if directors indicated direct provision of off-site HIV 
testing to at-risk individuals; (2) off-site HCV testing, a dichotomous variable set = 1 if 
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directors reported directly providing off-site hepatitis testing or immunizations to at-risk 
individuals and (3) other community outreach activities, a count variable with possible 
values ranging from 0 to 7, indicating how many of the following prevention strategies the 
OSAT used: talking to drug users on the streets or in places such as crack houses; talking to 
family members, friends, or acquaintances of drug users; performing hepatitis education 
outreach among at-risk individuals; distributing condoms; distributing clean needles; 
distributing bleach solutions in order to clean needles and exchanging clean needles for used 
ones.
Director boundary spanning behaviour was measured using five count variables based on 
director reports of the number of hours per week they spent on each activity, with potential 
responses ranging from 0 to a maximum of 60: (1) engaging in liaison activities with 
monitoring or licensing organizations; (2) engaging in activities with professional or 
occupational associations; (3) consulting with and exchanging information with other 
treatment providers; (4) contributing to policy making at the state or local levels and (5) 
making public presentations and appearances in the community.
A number of client case-mix variables, director attributes and organizational characteristics 
were included as covariates to control for potential confounders of focal estimates. Three 
measures of client case-mix were used as proxies for community prevention need: the 
percentage of clients entering treatment who were IDUs (Heimer, Grau, Curtin, Khoshnood, 
& Singer, 2007; Tempalski, Cleland, Pouget, Chatterjee, & Friedman, 2010), the percentage 
of clients entering treatment with co-occurring mental health and substance abuse disorders 
(Conover et al., 2009; Sherba & Singer, 2010) and the percentage of clients who were 
homeless upon entry into treatment (Reid, 1999).
Director attributes known to influence unit service provision include abstinence-oriented 
ideology of care and educational background. Previous research has shown that directors’ 
ideologies of care and educational background can influence the types of services OSATs 
provide (Clapp & Burke, 1997; Hasenfeld & Abbott, 1992). For example, Friedmann, Jiang, 
and Alexander (2010) found that senior managers’ treatment orientation influenced OSATs’ 
likelihood of offering buprenorphine services, while Pollack & D’Aunno (2008) found 
significant associations between managerial attitudes and dosage patterns in methadone 
treatment. Similarly, staff professional credentials have been associated with greater 
adoption of evidence-based practices and new technologies (Green, Rockhill, & Furrer, 
2007; Murphy et al., 1991), including prevention (Wells et al., 2006). In this study, 
abstinence-oriented ideology of care was operationalized as a dichotomous variable set = 1 
if complete abstinence was reported as the most important treatment goal and director has 
advanced educational degree as set = 1 if director reported having a degree more advanced 
than a college degree.
Organizational characteristics previously demonstrated to impact service provision in 
substance abuse treatment units include unit ownership (Ducharme, Mello, Roman, 
Knudsen, & Johnson, 2007; Olmstead, White, & Sindelar, 2004); methadone maintenance 
status (Sorenson & Copeland, 2000; Strauss, Astone, Hagan, & Des Jarlais, 2004); affiliation 
with hospitals or mental health centres (Strauss, Des Jarlais, Astone, & Vassilev, 2003); unit 
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size and unit location in a nonmetropolitan area. Unit size, operationalized as the number of 
active clients treated by the unit in the last year, was log-transformed because previous 
analyses have indicated a non-linear association between unit size and outcomes of interest 
(Lemak & Alexander, 2001). Unit location in a non-metropolitan area was measured using 
the Beale urbanicity code, which ranges from 0 (metropolitan centers with a population of 1 
million or greater) to 9 (rural areas with fewer than 20,000 residents not adjacent to a 
metropolitan center) (Beale, 2003); units were considered to be located in a non-
metropolitan area if they were assigned an urbanicity code of 4 or higher.
Analytic strategy
Separate logistic regression analyses were conducted for the dichotomous dependent 
variables measuring off-site HIV and HCV testing, respectively. A likelihood ratio test 
indicated that overdispersion was not present in the dependent variable measuring the 
breadth of other community outreach services; consequently, Poisson regression was 
identified as the correct model choice for this outcome (Long & Freese, 2006). All analyses 
used the Huber-White correction to ensure regression coefficients with heteroskedasticity-
robust standard errors (Wooldridge, 2006). Finally, Pearson’s and phi tests of bivariate 
correlation followed by tolerance checks (not shown) did not indicate any problematic 
collinearity among key independent variables. In addition, the mean variance inflation factor 
(VIF) for all model variables was less than 2.5 (Allison, 1999). However, the percentage of 
IDUs and the percentage of clients homeless upon entry into treatment were both negatively 
correlated with unit size (−0.43 and −0.49, respectively) and had individual VIFs of 3.77 and 
3.74 respectively, indicating a loss of precision in estimation for these covariates.
NDATSS developed selection weights to adjust for oversampling of certain types of 
programs and for survey non-response. Using these weights yielded descriptive statistics 
with generality to the national population of OSAT units, excluding active military, 
Veteran’s Administration, and correctional facility programs. In the regression models, 
stratification variables for unit ownership, organizational affiliation, and methadone status 
accomplished this level of generality.
RESULTS
Descriptive results
Table I provides unimputed and imputed summary descriptive statistics for all model 
variables. Approximately 47% of OSATs offered off-site HIV testing and 44% of units 
offered off-site hepatitis testing and/or immunization. On average, OSATs offered only one 
out of seven possible community outreach services. Separate examination (not shown) of 
each service indicated that active case finding techniques such as talking with family 
members, friends, or acquaintance of drug users or talking to drug users on the streets or in 
places such as crack houses were the most prevalent community outreach activities, followed 
closely by the distribution of condoms. Community outreach services commonly utilized in 
needle exchange programs – i.e. exchanging needles, distributing clean needles or bleach 
solution for cleaning needles – were by far the least common and offered by only 6.5% of 
units.
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On average, directors spent 2.64 h each week engaging in liaison activities with monitoring 
or licensing organizations, 1.6 h per week on activities with professional or occupational 
associations, 2.49 h per week consulting with other treatment providers, 1.69 h per week 
contributing to policymaking at the state or local levels and 2.25 h per week making public 
presentations in the community.
Multivariate regression results
Results of the final regression models are shown in Table II. Holding other factors equal, 
director engagement in liaison activities with monitoring or licensing organizations was 
positively associated with units’ odds of offering off-site HIV testing (OR 1.13, p < 0.05) 
and with the breadth of other community outreach services offered (IRR 1.04, p < 0.05). 
Similarly, director activities with professional or occupational associations were positively 
associated with unit odds of offering both off-site HIV testing (OR 1.39, p < 0.01) and 
hepatitis testing and/or immunizations (OR 1.44, p < 0.01). Director time spent making 
public presentations in the community was significantly associated with the breadth of other 
community outreach services offered (IRR 1.08, p < 0.01), such that every additional hour 
that directors spent each week making public presentations in the community was associated 
with an 8% increase in the incidence rate of community outreach services offered by 
OSATs.
Several covariates also emerged as significant. Having a director who favoured an abstinence 
ideology of care was negatively associated with the breadth of community outreach services 
provided (IRR 0.60, p < 0.01), i.e., an abstinence ideology reduced the breadth of 
community outreach services offered by 40%. However, an abstinence ideology of care was 
also positively associated with units’ odds of offering offsite HIV testing (OR 2.91, p < 0.05) 
and hepatitis testing and/or immunizations (OR 3.52, p < 0.01). Units whose directors had 
advanced educational degrees were more likely to provide off-site testing for both HIV and 
HCV (OR 5.25, p < 0.01 for HIV; OR 3.52, p < 0.01 for HCV) but did not differ in the 
breadth of other community outreach services provided.
Private-for-profit ownership was negatively associated with both units’ provision of HIV and 
HCV testing off-site (OR 0.01, p < 0.01 for HIV; OR 0.02, p < 0.01 for HCV) and with the 
breadth of other community outreach services provided (IRR 0.56, p < 0.05). Methadone 
maintenance status was positively associated with units’ provision of off-site testing (OR 
97.41, p < 0.01 for HIV; OR 71.93, p < 0.01 for HCV) but not significantly associated with 
provision of other community outreach services. Finally, hospital affiliation did not 
influence units’ odds of providing off-site testing for HIV or HCV, but was negatively 
associated with the breadth of other community outreach services provided by OSATs (IRR 
0.30, p < 0.01). Although the percentage of clients who were IDUs and number of clients 
were negatively associated with each dependent variable, bivariate correlations between 
these variables and the dependent variables were not significant, indicating that the 
coefficients in the multiple regressions were likely artefacts of the multicollinearity detected 
during preliminary analyses rather than true effects.
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This study examined the impact of directors’ boundary spanning activities on OSAT 
community outreach services, specifically off-site testing for HIV and HCV, active case 
finding, and harm-reduction interventions such as needle exchange. Three types of boundary 
spanning behaviours emerged as significant: first, the amount of time directors spent on 
liaison activities with licensing or monitoring organizations was positively associated with 
off-site HIV testing as well as with the breadth of other community outreach services 
provided. Second, the amount of time directors spent with professional and/or occupational 
associations was positively associated with unit provision of off-site testing for both HIV 
and HCV. Third, director time making public presentations in the community did not impact 
unit provision of off-site testing, but was positively associated with OSAT provision of non-
testing-related outreach activities such as reaching out to members of high-risk individuals’ 
sexual and social networks to promote testing, counselling, and care, or making bleach and 
clean needles available to drug users.
The current study findings are consistent with previous research suggesting that external 
environmental factors affect substance abuse treatment unit behaviour (D’Aunno, Sutton, & 
Price, 1991). Evaluations conducted by licensing and monitoring organizations serve as 
important quality signals to health and social service agencies and courts that refer clients to 
substance abuse treatment (Saufl & Fieldus, 2003), as well as to payers. These entities tend 
to emphasize prevention; therefore, directors attuned to their preferences may be more likely 
to devote unit resources to community outreach.
Professional associations also represent an important venue for directors to identify and 
track macro trends and best practices within the field of substance abuse treatment. Time 
devoted to these organizations may increase awareness of the increased emphasis on 
infectious disease testing by federal agencies such as NIH, CDC and SAMHSA (Kresina et 
al., 2007; SAMHSA, 2010). Involvement in professional associations may also help unit 
directors identify strategies for providing community outreach, such as grant opportunities. 
In addition, unit directors who are active in professional associations may have opportunities 
to share their prevention practices with peers, and thus receive more positive reinforcement 
for these activities.
Finally, directors who spend more time representing their units within the community may 
become more aware of local disease prevalence as well as where to focus outreach efforts. 
Presenting at community events may also help directors identify local partners to support 
prevention efforts. Community presentations may also facilitate local outreach by de-
stigmatizing behavioural health services.
Several covariates also predicted community outreach. The negative association between 
directors’ abstinence-orientation and unit provision of outreach services such as active case-
finding and harm reduction interventions is not surprising, given their ideological conflict 
with traditional approaches to substance abuse treatment advocated by Alcoholics 
Anonymous and other 12-step programs. In contrast, directors’ abstinence-orientation was 
positively associated with unit provision of off-site HIV and HCV testing. This finding is 
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consistent with a recent exploratory study of treatment program administrators within the 
National Drug Abuse Treatment Clinical Trials Network, which found that almost half of 
administrators felt that full abstinence from substance use was necessary for patients to 
succeed in reducing their involvement in high-risk behaviours, but only a very small 
minority (2%) of program administrators felt that providing medical services such as 
infectious disease testing would distract clients from focusing on the treatment of their 
substance abuse disorders (Bini et al., 2011). Efforts to promote the provision of prevention 
and outreach services among treatment units whose directors have a strong abstinence 
orientation may therefore be more successful if services are framed within a medical model 
of care and if they focus on testing and education.
Similarly, the findings that units whose directors have advanced degrees were more likely to 
offer off-site HIV and HCV testing may reflect greater exposure among these individuals to 
public health principles and practices. It is possible that continuing education will be an 
alternative way of promoting public health norms to directors with less formal education. It 
is also possible, however, that the associations between director degree and likelihood of 
providing testing in the community reflected slack resources that made it possible both to 
hire more expensive leadership and to provide uncompensated services.
Previous research suggests that methadone maintenance-treatment units are more likely to 
provide infectious disease testing and education (Strauss, Astone, Vassilev, Des Jarlais, & 
Hagan, 2003), but less likely to offer outreach services (Wells et al., 2006). In this study, 
methadone maintenance-treatment units had significantly greater odds of providing offsite 
HIV and HCV testing. However, there was no significant difference between methadone 
maintenance and drug-free treatment units in the provision of other community outreach 
services. Methadone maintenance-treatment units tend to serve clients with higher 
prevalence of HIV and viral hepatitis. Particularly with regards to HCV, secondary 
prevention has been described as more critical in methadone maintenance-treatment units, 
and primary prevention strategies more useful in drug-free treatment settings (Strauss et al., 
2004). The significant differences in off-site HIV and HCV testing between methadone 
maintenance and drug-free treatment units within our sample suggest the need for increased 
attention to the provision of these services by drug-free treatment units. In recent years, 
disease transmission attributable to risky sexual behaviours among drug users has increased, 
while transmission due to unsafe injection practices have stabilized (Des Jarlais et al., 2007; 
Lambert, Normand, & Volkow, 2010). This trend suggests the importance of increased 
prevention and outreach efforts by both drug-free and methadone maintenance-treatment 
units, as these disease epidemics are not limited to IDUs.
Limitations and future research
Several limitations should be considered when interpreting the study findings. First, the 
cross-sectional design of the data leaves the direction of causality uncertain. While the 
current study found director behaviours and attributes to be significantly associated with 
OSAT provision of community outreach services, it is possible that directors were more 
likely to obtain these positions if they espoused ideologies of care or possessed professional 
credentials that were consistent with pressures within units’ institutional environments. 
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Longitudinal study designs will be necessary to fully disentangle these effects. Second, as 
noted previously, two client case-mix variables and one organizational variable suffered 
from multicollinearity that limited their interpretation. Post-hoc analyses (not shown) 
indicated that findings related to the key independent variables were robust even when these 
covariates were omitted; however, having more detailed information about the extent to 
which unit service provision reflected client case-mix and/or local community needs would 
have been useful.
An additional limitation of the current study was the dichotomous nature of several key 
study variables (i.e. professional credentials, provision of any off-site testing). More granular 
analysis of how directors’ educational training impacts service provision could help identify 
gaps in current graduate curricula that could be addressed to better promote infectious 
disease prevention. Similarly, information on not just whether units provided community 
outreach services but the number of individuals that received them could help identify 
factors that differentiate units that are actively engaged in prevention from those who adopt 
services without actively implementing them due to external pressures.
Finally, while nationally representative of the US outpatient treatment system, the data used 
in this study were collected in 2005 and may not reflect the most recent trends in OSAT 
service provision. However, the recent recession and corresponding state cutbacks in 
behavioural health spending (Childrens Bureau, 2011) have made the current analysis 
increasingly topical. When competition for funding is high, directors tend to engage in more 
boundary spanning to better position their organizations for survival (Alexander et al., 
2008). At the same time, under-reimbursed activities such as prevention now rely more than 
ever on the commitment of local facility leadership. The most recent available data on 
environmental constraints experienced by substance abuse treatment units, which was 
collected prior to the 2008 economic downturn, suggested that funding constraints already 
prevented many programs from providing hepatitis testing or immunization, despite 
increasing prevalence of this disease (Bini et al., 2011). Understanding which relationships 
with external stakeholders are positively associated with OSAT community orientation can 
help activists and policymakers the most promising venues for encouraging directors to 
provide such services.
CONCLUSIONS
Although, substance abuse treatment units are heavily influenced by their environments, 
directors still exercise considerable discretion in the types of services offered. Despite 
increased emphasis on infectious disease prevention by federal and state agencies, provision 
of prevention services and particularly community outreach services remains relatively 
infrequent in the substance abuse treatment sector. Given the staggering societal costs and 
public health impact of the HIV and HCV epidemics, a better understanding of the factors 
that influence directors’ decision to implement prevention outreach services may be helpful 
to reducing the transmission of these diseases among substance users in the US
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